UBS Group’s IO Biotech IOBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4K | Buy |
13,259
+904
| +7% | +$1.26K | ﹤0.01% | 7187 |
|
|
2025
Q1 | $13.5K | Sell |
12,355
-34,675
| -74% | -$37.8K | ﹤0.01% | 7150 |
|
|
2024
Q4 | $43.3K | Sell |
47,030
-60,876
| -56% | -$56K | ﹤0.01% | 6170 |
|
|
2024
Q3 | $113K | Buy |
107,906
+104,626
| +3,190% | +$110K | ﹤0.01% | 5078 |
|
|
2024
Q2 | $3.84K | Buy |
+3,280
| New | +$3.84K | ﹤0.01% | 7006 |
|
|
2024
Q1 | – | Sell |
-11,204
| Closed | -$21.1K | – | 8365 |
|
|
2023
Q4 | $21.1K | Buy |
+11,204
| New | +$21.1K | ﹤0.01% | 5870 |
|
|
2022
Q3 | – | Sell |
-2,234
| Closed | -$10K | – | 9435 |
|
|
2022
Q2 | $10K | Buy |
+2,234
| New | +$10K | ﹤0.01% | 6928 |
|